Workflow
成功脱“坑”!天康生物2024年扭亏为盈,生猪养殖业务增长势头强劲,毛利率创近4年新高

Core Viewpoint - In 2024, the company achieved a turnaround in its financial performance, reporting a net profit of 605 million yuan, compared to a loss in the previous year, driven by improved production metrics in its food farming business and favorable market conditions [2][3]. Financial Performance - The company's 2024 revenue reached 17.176 billion yuan, slightly down from the previous year but marking the second-highest revenue in the past 20 years [3]. - The net profit for 2024 was 605 million yuan, successfully reversing a loss of 1.38 billion yuan in the previous year [3]. - The company's gross profit margin for 2024 reached 12.14%, an increase of over 9 percentage points from the previous year, indicating improved profitability [7]. Business Segments - The pig farming segment generated revenue of 6.157 billion yuan in 2024, accounting for 35.84% of total revenue, achieving a historical high in both revenue and proportion [5]. - The company reported a pig output of 3.0285 million heads in 2024, a year-on-year increase of 7.55%, with a target of 3.5 to 4 million heads for 2025 [5]. Research and Development - The company has been increasing its R&D investment, exceeding 200 million yuan in both 2023 and 2024, and has established a national-level enterprise technology center [2]. Dividend Policy - The company announced a cash dividend of 2.20 yuan per 10 shares for 2024, totaling 300 million yuan, which represents 25.32% of the distributable profit [10]. - The dividend payout ratio is close to 50%, reflecting the company's strong profitability and commitment to shareholder returns [10].